期刊文献+

脑抗氧化系统与帕金森病 被引量:2

下载PDF
导出
摘要 脑抗氧化系统的损害可能是帕金森病最初的神经生化改变,对帕金森病脑抗氧化系统功能的研究,可为帕金森病的临床治疗提供帮助。
作者 罗海彦
出处 《国外医学(老年医学分册)》 2001年第6期257-260,共4页 Foreign Medical Sciences(Geriatrics)
  • 相关文献

参考文献19

  • 1[1]Smith TS,Benhett JP.Mitochondrial toxins in neurodegener ative dise ase.In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis nifusion of methylpyridinium or azide ions. Brain Res,19 97;765:183~186
  • 2[2]Yu BP,Chen JJ,Kang CM.Mitochondrial aging and lipoperoxide products.Annals New York Acad Sci,1996;786:44~56
  • 3[3]Saidoune MM.Overproduction of cu/zn-superoxide dismutase or BCL-2 prevents t he brain mitochondrial respiratory dysfunction induced by glutathion.Exp Neurolo gy,1999;158:428~436
  • 4[4]Glinka Y,Youdim MBH.Inhibition of mitochondrial comlexes I and IV by 6-hydr oxydopamine.Eur J Pharmacol Environ Toxicol Pharmacol,1995;292:329~332
  • 5[5]Kumar R,Agarwal AK,Seth PK et al. Free radical-generated neurotoxiccit y of 6-hydrxydopamine.J Neurochem,1995;64(4):1703~1707
  • 6[6]Nishiyama K. CuZn-SOD-like immunoreactivity is present in lewy body inclusi ons from parkinson`s disease.Acta Neuropath,1995;89:471~474
  • 7[7]Swerdlow RH,Parks JK,Miller SW et al. Origin and functional consequenc es of the complex I defect in Parkinson`s disease.Annals Neurol,1996;40:663~671
  • 8[8]Benzi G,Moretti A.Age-and peroxidative stress-related modification of the cerebral enzymatc activites linked to mitochndria and glutathione system.Free Ra d Biol Med,1995;19:77~101
  • 9[9]LLic TV,Jovanovic M,Jovicio A et al. Oxidative stress indictors are el evated in de novo parkinson`s disease patients.Funct Neurol,1999;14(3):141~147
  • 10[10]Marshall KA,Reist M,Jenner P et al. The neuronal toxicity of su lfite plus peroxynitrice is ehanced by glutathione depletion implications for pa rkinson`s disease.Free Radic Biol Med,1999;27(5-6):515~520

同被引文献38

  • 1汪锡金,陈生弟,刘卫国,陆国强,梁梁,徐洁懿.免疫机制与帕金森病关系的研究[J].临床神经病学杂志,2004,17(4):241-243. 被引量:8
  • 2张玉平,彭国光.帕金森病与免疫异常[J].中国临床康复,2004,8(16):3108-3110. 被引量:2
  • 3陈生弟,周海燕.帕金森病发病机制的研究进展[J].中国实用内科杂志:临床前沿版,2006,26(2):246-248. 被引量:8
  • 4Ascherio A,Chen H,Schwarzschild MA,et al.Caffeine postmenopausal estrogen and risk of PD.Neurology,2003,60(5):790~795.
  • 5Dekker MC,Bonifati V,Van Duijn CM.Parkinson's disease:piecing together a genetic jigsaw.Brain,2003,126:1722~1733.
  • 6Orr CF,Rowe DB,Halliday GM,et al.An inflammatory review of Parkinson's disease.Prog Neurobiol,2002,68(5):325~340.
  • 7Chen S,Le WD,Xie WJ,et al.Experimental destruction of substantia nigra initiated by Parkinson disease inmunoglobulins.Arch Neurol,1998,55(8):1075~1080.
  • 8Zappia M,Crescibene L,Bosco D,et al.Anti-GM1 ganglioside antibodies in Parkinson's disease.Acta Neurol Scand,2002,106(1):54~57.
  • 9Hayes J,Tipton KF,Bianchi L,et al.Complexities in the neurotoxic actions of 6-hydroxydopamine in relation to the cytoprotective properties of taurine.Brain Res Bull,2001,55(2):239~245.
  • 10Zhang L,Dawson VL,Dawson TM.Role of nitric oxide in Parkinson's disease.Pharmacol Ther,2006,109(1~2):33~41.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部